Application, Verification, and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization
Elitza S. Theel(Mayo Clinic), Audrey N. Schuetz(Mayo Clinic), Marc Roger Couturier(University of Utah), Laura Filkins(The University of Texas Southwestern Medical Center), Elizabeth Palavecino, Vaishali Dharmarha(American Society for Microbiology), Sheldon Campbell(Yale University), Susan M. Butler‐Wu(University of Washington), Michael Pentella(University of Iowa), Peggy McNult(American Society for Microbiology), Stephanie L. Mitchell(University of Pittsburgh), Kurt Jerke(Madigan Army Medical Center)
Cited by 26
Related Papers
Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
|Clinical Infectious Diseases|2016|3k
Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization
|Cell Host & Microbe|2021|851
A Guide to Utilization of the Microbiology Laboratory for Diagnosis of Infectious Diseases: 2018 Update by the Infectious Diseases Society of America and the American Society for Microbiologya
|Clinical Infectious Diseases|2018|618
Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19
|New England Journal of Medicine|2021|553